Meropenem Kabi 500 mg pulveris injekciju vai infūziju šķīduma pagatavošanai Latvija - latviešu - Zāļu valsts aģentūra

meropenem kabi 500 mg pulveris injekciju vai infūziju šķīduma pagatavošanai

fresenius kabi polska sp.z o.o., poland - meropenēms - pulveris injekciju/infūziju šķīduma pagatavošanai - 500 mg

Meropenem Kabi 1000 mg pulveris injekciju vai infūziju šķīduma pagatavošanai Latvija - latviešu - Zāļu valsts aģentūra

meropenem kabi 1000 mg pulveris injekciju vai infūziju šķīduma pagatavošanai

fresenius kabi polska sp.z o.o., poland - meropenēms - pulveris injekciju/infūziju šķīduma pagatavošanai - 1000 mg

Byannli (previously Paliperidone Janssen-Cilag International) Eiropas Savienība - latviešu - EMA (European Medicines Agency)

byannli (previously paliperidone janssen-cilag international)

janssen-cilag international n.v.   - paliperidona palmitāts - Šizofrēnija - psihoterapija - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Comirnaty Eiropas Savienība - latviešu - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcīnas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. izmantojot šo vakcīnu, kas būtu saskaņā ar oficiālās rekomendācijas.

Tolfedine 4% injection 40 mg/ml šķīdums injekcijām Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

tolfedine 4% injection 40 mg/ml šķīdums injekcijām

vetoquinol s.a., francija - tolfenamīnskābe - šķīdums injekcijām - 40 mg/ml - kaķi; suņi

Orbeseal 2.6 g suspensija ievadīšanai tesmenī Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

orbeseal 2.6 g suspensija ievadīšanai tesmenī

zoetis belgium s.a., beļģija - bismuta subnitrāts - suspensija ievadīšanai tesmenī - 2.6 g - liellopi

Orbenin EDC 600 mg suspensija ievadīšanai tesmenī Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

orbenin edc 600 mg suspensija ievadīšanai tesmenī

zoetis belgium s.a., beļģija - kloksacilīns benzathine - suspensija ievadīšanai tesmenī - 600 mg - govis

Cobactan LC 75 mg ziede ievadīšanai tesmenī Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

cobactan lc 75 mg ziede ievadīšanai tesmenī

intervet international bv, nīderlande - cefquinome (kā cefquinome sulfate) - ziede ievadīšanai tesmenī - 75 mg - liellopi (laktējošas govis)

NuvaRing 0,120 mg/0,015 mg 24 stundās vaginālās ievadīšanas sistēma Latvija - latviešu - Zāļu valsts aģentūra

nuvaring 0,120 mg/0,015 mg 24 stundās vaginālās ievadīšanas sistēma

n.v. organon, netherlands - etonogestrelum, ethinylestradiolum - vaginālās ievadīšanas sistēma - 120/15 mikrogramu 24 stundās

Tetra-Delta suspensija ievadīšanai tesmenī Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

tetra-delta suspensija ievadīšanai tesmenī

zoetis belgium s.a., beļģija - novobiocin nātrija, penicilīna g prokaīna, dihidrostreptomicīns sulfāts, neomicīna sulfāts, prednizolons - suspensija ievadīšanai tesmenī - laktējošas govis